Drug Discovery Partnership

AFTD has formed a partnership with the Alzheimer’s Drug Discovery Foundation (ADDF) of New York to fund the first ever grants for FTD drug discovery. During each year of the partnership, AFTD contributes $100,000 and ADDF contributes $200,000 to fund researchers who worked to bridge the gap that exists between basic research in the laboratory, where the goal is to understand the fundamental biological processes that have gone awry, and development of a new therapeutic for clinical testing.